Straumann® Emdogain 015, USA. Enamel Matrix Derivative. Article Number 075.099
Published May 16, 2018 · Recall initiated: March 23, 2018
Summary
FDA records medical device Class II recall Z-1694-2018, published May 16, 2018 and initiated March 23, 2018. Recalling firm: Straumann Manufacturing, Inc.; Status: Terminated; Reported quantity: 3046; Lot: Lot LT830, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot LZ706, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot MG929, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot MT037, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot MZ441, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot NJ289, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot NJ579, Syringe Blister Lot NA438A, Exp 3/31/2019 Lot NP340, Syringe Blister Lot NA438A, Exp 3/31/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A change regarding the shelf life of a raw material was implemented without an appropriate submission of data demonstrating the continued efficacy of the product.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Straumann Manufacturing, Inc.
- Distributor
- Distributed US Nationwide and Puerto Rico.
- Lot
- Lot LT830, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot LZ706, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot MG929, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot MT037, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot MZ441, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot NJ289, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot NJ579, Syringe Blister Lot NA438A, Exp 3/31/2019 Lot NP340, Syringe Blister Lot NA438A, Exp 3/31/2019
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAIMMULITE ¿ 2000/IMMULITE ¿ 2000 XPi BR-MA (CA15-3)May 16, 2018
- FDASyngo.plaza software VB10A model numbers: 10863171, 10863172, 10863173 Syngo.Plaza is a Picture Archiving andMay 16, 2018
- FDAIMMULITE ¿ 2000/IMMULITE ¿ 2000 XPi GastrinMay 16, 2018
- FDAATTUNE Revision CRS Femoral RT SZ 5 Cemented, Catalog No. 150440205, Femoral Revision Implant, KneeMay 16, 2018
- FDAIMMULITE ¿ /IMMULITE 1000 ¿ GastrinMay 16, 2018
- FDABEQ-TOP 22702 ECC W/HMOD 30000, Catalog No. 701051179May 16, 2018
Questions about this recall
Was Straumann® Emdogain 015, USA. Enamel Matrix Derivative. Article Number 075.099 recalled?
Yes. FDA published recall Z-1694-2018 on May 16, 2018. Reported hazard: A change regarding the shelf life of a raw material was implemented without an appropriate submission of data demonstrating the continued efficacy of the product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter